Goldman Sachs delivered solid first-quarter results with $17.23 billion in revenue and earnings per share of $17.55, surpassing analyst expectations. Despite a 4% drop in stock price tied to market instability, the firm identifies potential in undervalued technology stocks and continues to see activity in M&A and IPOs. Additionally, Goldman Sachs has filed for a Bitcoin premium income ETF and reaffirmed buy ratings on stocks like Biogen and Netflix, highlighting its proactive approach to changing market conditions.

“Goldman Sachs is set to report first-quarter earnings.”

“I noticed um before we came on like Goldman Sachs just about a week ago, they reiterated their buy rating on Biogen.”
“It's not a great day for the banks already. Goldman, no. Stupid Goldman. Yeah, they're down 4%. uh right here.”
“posted revenue 17 billion, $1755 a share, beating $16.55 a share.”
“it says it's fixed income, currency, and commodities results fell short of expectations.”


“the next 72 hours are going to be instrumental for XRP and the rest of the crypto market. We just got five different bombshell updates over the course of this morning alone, which I am frankly in complete disbelief about and I am super excited to bring to all of you guys. Now, the very first thing that happened is we are seeing some of the largest institutions do some really interesting things. First and foremost, Goldman Sachs has filed for a Bitcoin premium income ETF.”
“Markets tend to overshoot, and Goldman Sachs -- in the person of its chief global equity strategist, Peter Oppenheimer -- believes this has left many otherwise over-performing companies undervalued. Oppenheimer was quoted as saying that the sell-off has 'opened up an opportunity in the technology sector where growth rates remain strong, but valuations are now low.'”
“Goldman says tech stocks are oversold. In an article published Friday, Goldman Sachs identified a 'value opportunity' in the tech sector. Goldman's upgrades and downgrades often move stocks significantly, as the investment bank is arguably the most influential market prognosticator...”